skip to main content

Chemistry, part 1

زبان محتوا

پشتیبانی: CRM@email.irandoc.ac.ir

Concept information

... > chemical entity > molecular entity > main group molecular entity > p-block molecular entity > carbon group molecular entity > organic molecular entity > n-acetyl-beta-d-galactosaminyl-(1->4)-beta-d-galactosyl-(1->3)-n-acetyl-beta-d-galactosaminyl-(1->4)-[n-acetyl-alpha-neuraminosyl-(2->3)]-beta-d-galactosyl-(1->4)-beta-d-glucosyl-(1<->1')-ceramide(d18:0)(1-)
... > chemical entity > molecular entity > main group molecular entity > p-block molecular entity > carbon group molecular entity > organic molecular entity > n-acetyl-beta-d-galactosaminyl-(1->4)-beta-d-galactosyl-(1->3)-n-acetyl-beta-d-galactosaminyl-(1->4)-[n-acetyl-alpha-neuraminosyl-(2->3)]-beta-d-galactosyl-(1->4)-beta-d-glucosyl-(1<->1')-ceramide(1-) > n-acetyl-beta-d-galactosaminyl-(1->4)-beta-d-galactosyl-(1->3)-n-acetyl-beta-d-galactosaminyl-(1->4)-[n-acetyl-alpha-neuraminosyl-(2->3)]-beta-d-galactosyl-(1->4)-beta-d-glucosyl-(1<->1')-ceramide(d18:0)(1-)
... > chemical entity > molecular entity > main group molecular entity > p-block molecular entity > carbon group molecular entity > organic molecular entity > lipid > sphingolipid > ceramide > ganglioside > sialopentaosylceramide > n-acetyl-beta-d-galactosaminyl-(1->4)-beta-d-galactosyl-(1->3)-n-acetyl-beta-d-galactosaminyl-(1->4)-[n-acetyl-alpha-neuraminosyl-(2->3)]-beta-d-galactosyl-(1->4)-beta-d-glucosyl-(1<->1')-ceramide(1-) > n-acetyl-beta-d-galactosaminyl-(1->4)-beta-d-galactosyl-(1->3)-n-acetyl-beta-d-galactosaminyl-(1->4)-[n-acetyl-alpha-neuraminosyl-(2->3)]-beta-d-galactosyl-(1->4)-beta-d-glucosyl-(1<->1')-ceramide(d18:0)(1-)
... > chemical entity > molecular entity > main group molecular entity > p-block molecular entity > pnictogen molecular entity > nitrogen molecular entity > organonitrogen compound > sphingolipid > ceramide > ganglioside > sialopentaosylceramide > n-acetyl-beta-d-galactosaminyl-(1->4)-beta-d-galactosyl-(1->3)-n-acetyl-beta-d-galactosaminyl-(1->4)-[n-acetyl-alpha-neuraminosyl-(2->3)]-beta-d-galactosyl-(1->4)-beta-d-glucosyl-(1<->1')-ceramide(1-) > n-acetyl-beta-d-galactosaminyl-(1->4)-beta-d-galactosyl-(1->3)-n-acetyl-beta-d-galactosaminyl-(1->4)-[n-acetyl-alpha-neuraminosyl-(2->3)]-beta-d-galactosyl-(1->4)-beta-d-glucosyl-(1<->1')-ceramide(d18:0)(1-)
... > organooxygen compound > sphingolipid > ceramide > ganglioside > sialopentaosylceramide > n-acetyl-beta-d-galactosaminyl-(1->4)-beta-d-galactosyl-(1->3)-n-acetyl-beta-d-galactosaminyl-(1->4)-[n-acetyl-alpha-neuraminosyl-(2->3)]-beta-d-galactosyl-(1->4)-beta-d-glucosyl-(1<->1')-ceramide(1-) > n-acetyl-beta-d-galactosaminyl-(1->4)-beta-d-galactosyl-(1->3)-n-acetyl-beta-d-galactosaminyl-(1->4)-[n-acetyl-alpha-neuraminosyl-(2->3)]-beta-d-galactosyl-(1->4)-beta-d-glucosyl-(1<->1')-ceramide(d18:0)(1-)
... > chemical entity > molecular entity > main group molecular entity > p-block molecular entity > pnictogen molecular entity > nitrogen molecular entity > organonitrogen compound > carboxamide > ceramide > ganglioside > sialopentaosylceramide > n-acetyl-beta-d-galactosaminyl-(1->4)-beta-d-galactosyl-(1->3)-n-acetyl-beta-d-galactosaminyl-(1->4)-[n-acetyl-alpha-neuraminosyl-(2->3)]-beta-d-galactosyl-(1->4)-beta-d-glucosyl-(1<->1')-ceramide(1-) > n-acetyl-beta-d-galactosaminyl-(1->4)-beta-d-galactosyl-(1->3)-n-acetyl-beta-d-galactosaminyl-(1->4)-[n-acetyl-alpha-neuraminosyl-(2->3)]-beta-d-galactosyl-(1->4)-beta-d-glucosyl-(1<->1')-ceramide(d18:0)(1-)
... > organooxygen compound > carboxamide > ceramide > ganglioside > sialopentaosylceramide > n-acetyl-beta-d-galactosaminyl-(1->4)-beta-d-galactosyl-(1->3)-n-acetyl-beta-d-galactosaminyl-(1->4)-[n-acetyl-alpha-neuraminosyl-(2->3)]-beta-d-galactosyl-(1->4)-beta-d-glucosyl-(1<->1')-ceramide(1-) > n-acetyl-beta-d-galactosaminyl-(1->4)-beta-d-galactosyl-(1->3)-n-acetyl-beta-d-galactosaminyl-(1->4)-[n-acetyl-alpha-neuraminosyl-(2->3)]-beta-d-galactosyl-(1->4)-beta-d-glucosyl-(1<->1')-ceramide(d18:0)(1-)
... > chemical entity > molecular entity > main group molecular entity > p-block molecular entity > pnictogen molecular entity > nitrogen molecular entity > amide > primary amide > carboxamide > ceramide > ganglioside > sialopentaosylceramide > n-acetyl-beta-d-galactosaminyl-(1->4)-beta-d-galactosyl-(1->3)-n-acetyl-beta-d-galactosaminyl-(1->4)-[n-acetyl-alpha-neuraminosyl-(2->3)]-beta-d-galactosyl-(1->4)-beta-d-glucosyl-(1<->1')-ceramide(1-) > n-acetyl-beta-d-galactosaminyl-(1->4)-beta-d-galactosyl-(1->3)-n-acetyl-beta-d-galactosaminyl-(1->4)-[n-acetyl-alpha-neuraminosyl-(2->3)]-beta-d-galactosyl-(1->4)-beta-d-glucosyl-(1<->1')-ceramide(d18:0)(1-)
... > chemical entity > molecular entity > main group molecular entity > p-block molecular entity > carbon group molecular entity > organic molecular entity > lipid > liposaccharide > glycolipid > glycosphingolipid > acidic glycosphingolipid > ganglioside > sialopentaosylceramide > n-acetyl-beta-d-galactosaminyl-(1->4)-beta-d-galactosyl-(1->3)-n-acetyl-beta-d-galactosaminyl-(1->4)-[n-acetyl-alpha-neuraminosyl-(2->3)]-beta-d-galactosyl-(1->4)-beta-d-glucosyl-(1<->1')-ceramide(1-) > n-acetyl-beta-d-galactosaminyl-(1->4)-beta-d-galactosyl-(1->3)-n-acetyl-beta-d-galactosaminyl-(1->4)-[n-acetyl-alpha-neuraminosyl-(2->3)]-beta-d-galactosyl-(1->4)-beta-d-glucosyl-(1<->1')-ceramide(d18:0)(1-)
... > organooxygen compound > carbohydrates and carbohydrate derivatives > carbohydrate derivative > liposaccharide > glycolipid > glycosphingolipid > acidic glycosphingolipid > ganglioside > sialopentaosylceramide > n-acetyl-beta-d-galactosaminyl-(1->4)-beta-d-galactosyl-(1->3)-n-acetyl-beta-d-galactosaminyl-(1->4)-[n-acetyl-alpha-neuraminosyl-(2->3)]-beta-d-galactosyl-(1->4)-beta-d-glucosyl-(1<->1')-ceramide(1-) > n-acetyl-beta-d-galactosaminyl-(1->4)-beta-d-galactosyl-(1->3)-n-acetyl-beta-d-galactosaminyl-(1->4)-[n-acetyl-alpha-neuraminosyl-(2->3)]-beta-d-galactosyl-(1->4)-beta-d-glucosyl-(1<->1')-ceramide(d18:0)(1-)
... > chemical entity > molecular entity > main group molecular entity > p-block molecular entity > carbon group molecular entity > organic molecular entity > lipid > sphingolipid > glycosphingolipid > acidic glycosphingolipid > ganglioside > sialopentaosylceramide > n-acetyl-beta-d-galactosaminyl-(1->4)-beta-d-galactosyl-(1->3)-n-acetyl-beta-d-galactosaminyl-(1->4)-[n-acetyl-alpha-neuraminosyl-(2->3)]-beta-d-galactosyl-(1->4)-beta-d-glucosyl-(1<->1')-ceramide(1-) > n-acetyl-beta-d-galactosaminyl-(1->4)-beta-d-galactosyl-(1->3)-n-acetyl-beta-d-galactosaminyl-(1->4)-[n-acetyl-alpha-neuraminosyl-(2->3)]-beta-d-galactosyl-(1->4)-beta-d-glucosyl-(1<->1')-ceramide(d18:0)(1-)
... > chemical entity > molecular entity > main group molecular entity > p-block molecular entity > pnictogen molecular entity > nitrogen molecular entity > organonitrogen compound > sphingolipid > glycosphingolipid > acidic glycosphingolipid > ganglioside > sialopentaosylceramide > n-acetyl-beta-d-galactosaminyl-(1->4)-beta-d-galactosyl-(1->3)-n-acetyl-beta-d-galactosaminyl-(1->4)-[n-acetyl-alpha-neuraminosyl-(2->3)]-beta-d-galactosyl-(1->4)-beta-d-glucosyl-(1<->1')-ceramide(1-) > n-acetyl-beta-d-galactosaminyl-(1->4)-beta-d-galactosyl-(1->3)-n-acetyl-beta-d-galactosaminyl-(1->4)-[n-acetyl-alpha-neuraminosyl-(2->3)]-beta-d-galactosyl-(1->4)-beta-d-glucosyl-(1<->1')-ceramide(d18:0)(1-)
... > organooxygen compound > sphingolipid > glycosphingolipid > acidic glycosphingolipid > ganglioside > sialopentaosylceramide > n-acetyl-beta-d-galactosaminyl-(1->4)-beta-d-galactosyl-(1->3)-n-acetyl-beta-d-galactosaminyl-(1->4)-[n-acetyl-alpha-neuraminosyl-(2->3)]-beta-d-galactosyl-(1->4)-beta-d-glucosyl-(1<->1')-ceramide(1-) > n-acetyl-beta-d-galactosaminyl-(1->4)-beta-d-galactosyl-(1->3)-n-acetyl-beta-d-galactosaminyl-(1->4)-[n-acetyl-alpha-neuraminosyl-(2->3)]-beta-d-galactosyl-(1->4)-beta-d-glucosyl-(1<->1')-ceramide(d18:0)(1-)

اصطلاح مرجح

n-acetyl-beta-d-galactosaminyl-(1->4)-beta-d-galactosyl-(1->3)-n-acetyl-beta-d-galactosaminyl-(1->4)-[n-acetyl-alpha-neuraminosyl-(2->3)]-beta-d-galactosyl-(1->4)-beta-d-glucosyl-(1<->1')-ceramide(d18:0)(1-)  

نوع

  • http://www.irandoc.ac.ir/onto/irandoc-meta/Concept

مفهوم اعم

بار

  • -1

فرمول

  • C64H110N4O36R

جرم

  • 1511.566

جرم تک‌ایزوتوپی

  • 1510.68998

اسمایلٓ

  • [C@@]1(O[C@H]2[C@H]([C@H](O[C@H]([C@@H]2O)O[C@@H]3[C@H](O[C@@H](OC[C@@H]([C@@H](CCCCCCCCCCCCCCC)O)NC(=O)*)[C@@H]([C@H]3O)O)CO)CO)O[C@H]4[C@@H]([C@H]([C@@H](O)[C@H](O4)CO)O[C@@H]5O[C@@H]([C@@H]([C@@H]([C@H]5O)O)O[C@H]6[C@@H]([C@H]([C@@H](O)[C@H](O6)CO)O)NC(C)=O)CO)NC(C)=O)(O[C@]([C@H](NC(=O)C)[C@H](C1)O)([C@@H]([C@H](O)CO)O)[H])C([O-])=O

زیرمجموعه

  • 2_STAR

مترادف مرتبط

  • beta-D-GalNAc-(1->4)-beta-D-Gal-(1->3)-beta-D-GalNAc-(1->4)-[alpha-NeuAc-(2->3)]-beta-D-Gal-(1->4)-beta-D-Glc-(1<->1')-Cer(d18:0)(1-)
  • GalNAc-GM1(d18:0)(1-)
  • ganglioside GalNAc-GM1 (d18:0)
  • N-acetyl-beta-D-galactosaminyl-(1->4)-beta-D-galactosyl-(1->3)-N-acetyl-beta-D-galactosaminyl-(1->4)-[N-acetyl-alpha-neuraminosyl-(2->3)]-beta-D-galactosyl-(1->4)-beta-D-glucosyl-(1<->1')-N-acylsphinganine(1-)

در زبان های دیگر

URI

http://www.irandoc.acir/onto/irandoc/CHEBI:141807

این مفهوم را بارگیری کن:

RDF/XML TURTLE JSON-LD